Nothing Special   »   [go: up one dir, main page]

Levin et al., 1987 - Google Patents

Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.

Levin et al., 1987

View PDF
Document ID
17666558221364894746
Author
Levin E
Santell L
Publication year
Publication venue
The Journal of cell biology

External Links

Snippet

We have studied the distribution of the plasminogen activator inhibitor type 1 (PAI-1) in cultures of confluent human umbilical vein endothelial cells. Plasminogen activator inhibitor activity measured by the 125I-fibrin plate assay was detected in the cytosol (2.85+/-0.16 U) …
Continue reading at www.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general

Similar Documents

Publication Publication Date Title
Levin et al. Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.
Mimuro et al. Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor
Pöllänen et al. Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells
Stump et al. Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator.
Salonen et al. Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin.
Schäfer et al. Plasminogen activation in healing human wounds.
Knudsen et al. Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.
Hekman et al. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator
Plow et al. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.
Wun et al. A proenzyme form of human urokinase.
Van Hinsbergh et al. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium
Andreasen et al. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
Hekman et al. Fibrinolytic pathways and the endothelium
Collen et al. Fast-acting plasmin inhibitor in human plasma
Eaton et al. Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin.
Ellis et al. Potentiation of plasminogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation. A mechanistic model for receptor-mediated plasminogen activation.
Loskutoff et al. Interactions between fibrin and the plasminogen activators produced by cultured endothelial cells
Lacave et al. Characterization of a plasminogen activator and its inhibitor in human mesangial cells
Wang et al. Latent and active plasminogen activator in corneal ulceration.
Booth et al. Plasminogen activator inhibitor from human endothelial cells: purification and partial characterization
Mannucci et al. Congenital plasminogen deficiency associated with venous thromboembolism: therapeutic trial with stanozolol
Malinconico et al. Hementin: anticoagulant protease from the salivary gland of the leech Haementeria ghilianii
Hayashi et al. Pathogenesis of corneal epithelial defects: role of plasminogen activator
Erickson et al. Denaturant-induced stimulation of the β-migrating plasminogen activator inhibitor in endothelial cells and serum
Hoffman et al. Wound fluid from venous leg ulcers degrades plasminogen and reduces plasmin generation by keratinocytes